Отчет об анализе размера, доли и тенденций рынка аллотрансплантатов стопы и голеностопного сустава в Азиатско-Тихоокеанском регионе – Обзор отрасли и прогноз до 2031 года

Анализ рынка аллотрансплантатов стопы и голеностопного сустава в Азиатско-Тихоокеанском регионе

Рост распространенности ортопедических заболеваний, а также заболеваний стопы и голеностопного сустава, наряду с ростом непрерывной коммерциализации продукции и ростом численности населения пожилого возраста, являются основными факторами, которые стимулировали спрос на рынке в прогнозируемый период.

Высокие затраты, связанные с устройствами для аллотрансплантации стопы и голеностопного сустава, а также отсутствие формального образования и обучения могут помешать будущему росту рынка аллотрансплантации стопы и голеностопного сустава в Азиатско-Тихоокеанском регионе. Партнерства и поглощения основными игроками рынка являются возможностью для роста рынка аллотрансплантации стопы и голеностопного сустава.

Размер рынка аллотрансплантатов стопы и голеностопного сустава в Азиатско-Тихоокеанском регионе

Объем рынка аллотрансплантатов стопы и голеностопного сустава в Азиатско-Тихоокеанском регионе в 2023 году оценивался в 158,28 млн долларов США и, по прогнозам, к 2031 году достигнет 292,97 млрд долларов США, при этом среднегодовой темп роста составит 8,00% в прогнозируемый период с 2024 по 2031 год.

Область отчета и сегментация рынка       

Определение рынка аллотрансплантатов стопы и голеностопного сустава

Foot and ankle allografts is a technique used in a number of medical procedures to save lives, repair limbs, and relieve pain in the patient by transplanting a cell or a tissue from one person to another. The donor should be non-identical, of the same species but of a different genotype. Allografts are used for various treatment and procedures such as orthopedic reconstruction, cartilage restoration, soft tissue tendon & ligament repair and wound care. Allografts are most commonly used in reconstructive surgeries around the foot and ankle. Compared to autograft tissue, allografts provide advantages such as less operative time, unlimited tissue sources, and lack of potential donors-site morbidity.

Foot and Ankle Allografts Market Dynamics

Drivers

• Growing Geriatric Population

Geriatric population are more prone to the conditions leading to fragile bones and joints. In such patients allografts are used in the procedure to provide them immediate and efficient benefits associated with their body.

• Increase in Prevalence of Musculoskeletal Disorder

Musculoskeletal disorders comprises of fractures associated with bone fragility, osteoarthritis, injuries and systemic inflammatory conditions such as rheumatoid arthritis. Allografts have been used to correct these deformities or to fill bone defects secondary to trauma, osteochondral lesions, or intercalary arthrodesis.

Restraint

• Stringent Regulatory

The allografts are regulated by a structure of laws, rules, and regulations that are extensive and complex to safeguard them from use in any potential harmful treatment. The need for more stringent privacy policies and regulations has limited the growth of this market

Opportunity

• Increasing Reimbursement Policies

Increasing Universal Health Coverage (UHC) is widely believed to drive better patient accessibility to healthcare systems. Moreover, a number of organizations have initiated reimbursement policies. The policies programs help in covering healthcare needs of population are expected to create a significant opportunity for the market.

Challenge

• Lack of Awareness for Foot and Ankle Solutions

A large number of population suffers from foot and ankle cases in underdeveloped countries. These cases tend to get neglected or mismanaged, as ankle orthopedics has yet to establish itself as the specialty of orthopedics in developing countries. Moreover, lack of knowledge about the availability of foot and ankle solutions in society as well as in medical population pose as a major challenge for the market.

Foot and Ankle Allografts Market Scope

Asia-Pacific foot and ankle allografts market is segmented on the basis of product type, surgery type, procedure and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Product Type

• Allograft Wedges
• Allograft Tendons
• Allograft Acellular Dermal Matrix
• Cartilage Allograft Matrix
• Skin Allografts
• Amniotic Membranes

Surgery Type

• Orthopaedic Reconstruction
• Cartilage Restoration
• Soft Tissue Tendon and Ligament Repair
• Wound Care

Procedure

• Midfoot Procedures
• Hindfoot Procedures

End User

• Hospitals
• Orthopaedic Clinics
• Ambulatory Surgical Centres
• Academic and Research Institutes
• Other End Users

Asia-Pacific Foot and Ankle Allografts Market Regional Analysis

The foot and ankle allografts market is analyzed and market size information is provided by product type, surgery type, procedure and end user.

The countries covered in the Asia-Pacific foot and ankle allograft market report are the China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific.

China is expected to dominate the market due to the increasing geriatric population and is expected to grow due to rise in continuous product commercialization.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Asia-Pacific Foot and Ankle Allografts Market Share

Foot and ankle allografts market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the foot and ankle allografts market.

Foot and Ankle Allografts Market Leaders Operating in the Market Are:

• LifeNet Health (U.S.)
• Zimmer Biomet (U.S.)
• Johnson and Johnson services Inc (U.S.)
• Integra LifeSciences (U.S.)
• CONMED Corporation. (U.S.)

Latest Developments in Foot and Ankle Allografts Market

• In March 2022, Lifenet Health announce that they will be showcasing their innovative all-human research solutions at SOT ToxExpo which has increased company’s customer’s engagement
• In March 2022, Zimmer Biomet announced that they have sign a multiyear agreement with Biocomposites to exclusively distribute genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. orthopaedic market. This will help company to increase their revenue and sales
• В августе 2021 года Johnson & Johnson Services Inc. объявила, что их компания DePuy Synthes представила свои новые продукты и технологические решения, формирующие новые стандарты ухода за современной ортопедией, на ежегодном собрании Американской академии ортопедических хирургов (AAOS). Это помогло компании привлечь больше клиентов и увеличить продажи

SKU-15632